Abstract
Despite major advances in molecular oncology and cancer therapeutics, early detection remains a critical limitation for many malignancies. Current screening approaches rely largely on anatomical or morphological changes, highlighting a persistent gap between modern biological understanding of cancer and its clinical application. This article examines the evolution of cancer biology and explores why these advances have not yet translated into effective early detection strategies.
I propose a wearable device–based framework that integrates peripheral blood DNA methylation profiling of tumor suppressor genes and oncogenes with physical detection of early malignant cells. Technologies such as superconducting quantum interference devices (SQUID), metamaterial sensors, and microwave imaging are discussed as platforms for three-dimensional localization of nascent cancer cells. In parallel, “elimination” wearable devices capable of delivering localized energy—via radiofrequency or microwave ablation, nanoparticles, or programmable nanomachines—are proposed to eradicate malignant cells at inception.
This integrative model bridges molecular oncology, applied physics, and digital health, introducing a new paradigm for early cancer detection and prevention.
Keywords
Cancer screening, SQUID, Nano-machines, Meta material sensor, Electromagnetic field, Microwave imaging, Radio frequency ablation, Digital oncology